LAURA BLACK: Open Payments
NPI 1760748131 · GONZALES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$649 in 38 payments from 11 companies in 2025. Trend: 2023 $699 · 2024 $566 · 2025 $649
Food & beverage: $649
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $192 |
| GlaxoSmithKline, LLC. | 10 | $185 |
| Axsome Therapeutics, Inc. | 2 | $53 |
| Vanda Pharmaceuticals Inc. | 2 | $41 |
| Antares Pharma, Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $36 |
| Exact Sciences Corporation | 2 | $30 |
| PFIZER INC. | 1 | $20 |
| Abbott Laboratories | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: TRELEGY ELLIPTA, VRAYLAR, UBRELVY, Auvelity, QULIPTA, FANAPT, XYOSTED, MOUNJARO.
Industry payments across LA — which companies pay providers there.
